» Articles » PMID: 23451145

Predominance of HA-222D/G Polymorphism in Influenza A(H1N1)pdm09 Viruses Associated with Fatal and Severe Outcomes Recently Circulating in Germany

Overview
Journal PLoS One
Date 2013 Mar 2
PMID 23451145
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza A(H1N1)pdm09 viruses cause sporadically very severe disease including fatal clinical outcomes associated with pneumonia, viremia and myocarditis. A mutation characterized by the substitution of aspartic acid (wild-type) to glycine at position 222 within the haemagglutinin gene (HA-D222G) was recorded during the 2009 H1N1 pandemic in Germany and other countries with significant frequency in fatal and severe cases. Additionally, A(H1N1)pdm09 viruses exhibiting the polymorphism HA-222D/G/N were detected both in the respiratory tract and in blood. Specimens from mild, fatal and severe cases were collected to study the heterogeneity of HA-222 in A(H1N1)pdm09 viruses circulating in Germany between 2009 and 2011. In order to enable rapid and large scale analysis we designed a pyrosequencing (PSQ) assay. In 2009/2010, the 222D wild-type of A(H1N1)pdm09 viruses predominated in fatal and severe outcomes. Moreover, co-circulating virus mutants exhibiting a D222G or D222E substitution (8/6%) as well as HA-222 quasispecies were identified (10%). Both the 222D/G and the 222D/G/N/V/Y polymorphisms were confirmed by TA cloning. PSQ analyses of viruses associated with mild outcomes revealed mainly the wild-type 222D and no D222G change in both seasons. However, an increase of variants with 222D/G polymorphism (60%) was characteristic for A(H1N1)pdm09 viruses causing fatal and severe cases in the season 2010/2011. Pure 222G viruses were not observed. Our results support the hypothesis that the D222G change may result from adaptation of viral receptor specificity to the lower respiratory tract. This could explain why transmission of the 222G variant is less frequent among humans. Thus, amino acid changes at HA position 222 may be the result of viral intra-host evolution leading to the generation of variants with an altered viral tropism.

Citing Articles

An Investigation of Severe Influenza Cases in Russia during the 2022-2023 Epidemic Season and an Analysis of HA-D222G/N Polymorphism in Newly Emerged and Dominant Clade 6B.1A.5a.2a A(H1N1)pdm09 Viruses.

Kolosova N, Boldyrev N, Svyatchenko S, Danilenko A, Goncharova N, Shadrinova K Pathogens. 2024; 13(1).

PMID: 38276147 PMC: 10819184. DOI: 10.3390/pathogens13010001.


Genetic Diversity of Type A Influenza Viruses Found in Swine Herds in Northwestern Poland from 2017 to 2019: The One Health Perspective.

Rabalski L, Kosinski M, Cybulski P, Stadejek T, Lepek K Viruses. 2023; 15(9).

PMID: 37766299 PMC: 10536349. DOI: 10.3390/v15091893.


Whole-Genome Sequence Approach and Phylogenomic Stratification Improve the Association Analysis of Mutations With Patient Data in Influenza Surveillance.

Van Poelvoorde L, Vanneste K, de Keersmaecker S, Thomas I, Van Goethem N, Van Gucht S Front Microbiol. 2022; 13:809887.

PMID: 35516436 PMC: 9063638. DOI: 10.3389/fmicb.2022.809887.


A Comprehensive Molecular and Epidemiological Characterization of Influenza Viruses Circulating 2016-2020 in North Macedonia.

Kuzmanovska M, Boshevska G, Janchevska E, Buzharova T, Simova M, Peshnacka A Front Microbiol. 2021; 12:713408.

PMID: 34745027 PMC: 8567633. DOI: 10.3389/fmicb.2021.713408.


Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients.

Van Goethem N, Serrien B, Vandromme M, Wyndham-Thomas C, Catteau L, Brondeel R Arch Public Health. 2021; 79(1):185.

PMID: 34696806 PMC: 8543112. DOI: 10.1186/s13690-021-00709-x.


References
1.
Khouzam R, Parizianu C, Hafiz A, Chawla S, Schwartz R . Fulminant myocarditis associated with novel H1N1 influenza A. Heart Lung. 2011; 40(6):566-8. DOI: 10.1016/j.hrtlng.2011.01.004. View

2.
Morera D, MacKenzie S . Is there a direct role for erythrocytes in the immune response?. Vet Res. 2011; 42:89. PMC: 3199785. DOI: 10.1186/1297-9716-42-89. View

3.
Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, Takada A . Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One. 2010; 5(1):e8553. PMC: 2797400. DOI: 10.1371/journal.pone.0008553. View

4.
Stevens J, Corper A, Basler C, Taubenberger J, Palese P, Wilson I . Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science. 2004; 303(5665):1866-70. DOI: 10.1126/science.1093373. View

5.
Weinheimer V, Becher A, Tonnies M, Holland G, Knepper J, Bauer T . Influenza A viruses target type II pneumocytes in the human lung. J Infect Dis. 2012; 206(11):1685-94. PMC: 7107318. DOI: 10.1093/infdis/jis455. View